Pennsylvania physicians who are licensed, registered, or otherwise lawfully authorized to prescribe controlled substances, other drugs or devices in the course of professional practice or research in Pennsylvania are required to register in the state's prescription drug monitoring program (PDMP).
Physicians should take the following steps to understand their responsibilities with this new law:
PAMED Advocacy and the PDMP
Several physicians have asked what PAMED did and is continuing to do to advocate on their behalf in regards to the state's PDMP.
Throughout the development of Pennsylvania's PDMP, PAMED urged policymakers to provide physicians with an effective tool to help identify patients at risk of developing an opioid addiction while working to preserve physicians' autonomy and clinical judgement.
When legislation was proposed that would have required physicians to also query the PDMP every time before prescribing a controlled substance, PAMED was at the table in ongoing discussions and was successful in getting the additional requirement limited to only benzodiazepines and opioids.
When the PDMP launched in August 2016, PAMED compiled physician questions and concerns on a regular basis and shared them with the Pennsylvania Department of Health (DOH).
PAMED has also sent follow up letters with questions and concerns to DOH.